BioIntelliSense

BioIntelliSense (operating under biointellisense.com) is a pioneering, clinical-grade medical intelligence and continuous health monitoring company that is transforming patient care from the hospital to the home. Founded in 2018 by renowned digital health innovator Dr. James Mault, the company designs and manufactures medical-grade wearable devices alongside advanced AI-driven analytics systems. The company's flagship product ecosystem includes the BioButton®, a discreet, multi-parameter, single-use wearable sensor that continuously tracks a patient's vital signs—including skin temperature, respiratory rate at rest, resting heart rate, body position, activity level, and sleep status—for up to 30 days on a single device. Powered by its sophisticated BioCloud™ data analytics platform and clinical intelligence engine, BioIntelliSense aggregates millions of data points to generate personalized baselines, surface high-resolution trending insights, and trigger algorithmic algorithmic alerts for early clinical deterioration before an adverse event occurs. The company's solutions are deeply integrated into leading hospital networks, remote patient monitoring (RPM) programs, and decentralized clinical trials to automate ambient patient workflows, optimize clinical staffing efficiency, reduce hospital readmission rates, and lower overall healthcare delivery costs. Headquartered in Denver, Colorado, with institutional backing from prominent healthcare and technology investors, BioIntelliSense stands as a critical architect of scalable, data-driven, and proactive predictive health monitoring infrastructure.